Cell And Gene Therapies: Where Few Standard Rules Apply

The main rule of the cell and gene therapy market is there are few hard and fast rules when it comes to how to manufacture, distribute, administer and price these potentially curative treatments for cancer and rare diseases.

Without a standard set of rules agreed to by the therapies' developers, the first companies with approved products – along with their vendors, treating physicians and payers – will dictate the complex path forward